🇺🇸 Typherix in United States

21 US adverse-event reports

Marketing authorisation

FDA

• Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 27 March 2025 – 27 March 2026
• Total reports: 21

Most-reported reactions

1. Drug Exposure During Pregnancy — 6 reports (28.57%)
2. Urticaria — 3 reports (14.29%)
3. Urticaria Chronic — 3 reports (14.29%)
4. Abortion — 2 reports (9.52%)
5. Abortion Induced — 2 reports (9.52%)
6. Abdominal Pain — 1 report (4.76%)
7. Abortion Spontaneous — 1 report (4.76%)
8. Cholecystitis Chronic — 1 report (4.76%)
9. Cholelithiasis — 1 report (4.76%)
10. Gallbladder Disorder — 1 report (4.76%)

Source database →

Frequently asked questions

Is Typherix approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Typherix in United States?

Helsinki University Central Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.